CanniMed CEO resigns as Aurora acquisition nears completion

The Canadian Press
April 03, 2018
By The Canadian Press
The chief executive officer of CanniMed Therapeutics has resigned, effective immediately, as Aurora Cannabis wraps up its acquisition of the medical marijuana company.
According to a statement issued by the companies, CEO Brent Zettl, who helped co-found the Saskatoon-based licensed producer in 1988, is pursuing other opportunities.

He has agreed to remain available to CanniMed and Aurora as they integrate the two companies.

Aurora's senior vice-president of business integration Andre Jerome has been appointed as interim chief executive.

In January, Aurora struck a stock-and-cash deal valued at $1.1 billion to buy CanniMed.

The agreement ended a sometimes-terse takeover battle between the two marijuana companies.
Grow Opportunity
GET CONNECTED

Stay in-the-know on innovative ways to manage your cannabis business, and grow better. Subscribe to our bi-weekly eNewsletter and be the first to hear what’s new in this fast growing industry.

Add comment


Security code
Refresh

Subscription Centre

 
New Subscription
 
Already a Subscriber
 
Customer Service
 
View Digital Magazine Renew

Most Popular